Published Dec 22, 2022

HIBT Lab! Immunai: Noam Solomon

Guy Raz speaks with Noam Solomon, CEO of Immunai, about how the company is using AI-driven immune mapping to revolutionize personalized drug therapies, tackle challenges in biotech, and improve clinical trials and treatments for diseases like cancer.

Episode Highlights

Topics covered

Episode Highlights

Related Episodes

HIBT Lab! Gro Intelligence: Sara Menker
Answers 383 questions
HIBT Lab! Nas Company: Nuseir Yassin
Answers 383 questions
HIBT Lab! Tomorrow.io: Shimon Elkabetz
Answers 383 questions
HIBT Lab! Goodr: Jasmine Crowe-Houston
Answers 383 questions
HIBT Lab! SOURCE Global: Cody Friesen
Answers 383 questions
HIBT Lab! Wonder: Marc Lore
Answers 383 questions
HIBT Lab! Colin and Samir: Colin Rosenblum and Samir Chaudry
Answers 383 questions
ICYMI... HIBT Lab! Colin and Samir: Colin Rosenblum and Samir Chaudry
Answers 383 questions
HIBT Lab! OpenAI: Sam Altman
Answers 383 questions
HIBT Lab! Wildtype: Aryé Elfenbein and Justin Kolbeck
Answers 383 questions
HIBT Lab! Armbrust American: Lloyd Armbrust
Answers 383 questions
HIBT Lab! Biobot Analytics: Mariana Matus and Newsha Ghaeli
Answers 383 questions
HIBT Lab! New Culture: Matt Gibson and Inja Radman
Answers 383 questions
HIBT Lab! Universal Hydrogen: Paul Eremenko
Answers 383 questions
HIBT Lab! Boom Supersonic: Blake Scholl
Answers 383 questions

Dexa/Guy Raz

HIBT Lab! Immunai: Noam Solomon

Topics covered

Popular Clips

Mapping Human Immune System

Transforming Medicine

Revolutionizing Immunotherapy Development

Immune Response Insights

AI Revolution

Innovative Biotech Ventures

Building Success

Mapping Human Immune System

LinkedIn Ads Empower

Revolutionary Immune Database

Revolutionizing Immune System Analysis

Building Immuneye

Hip Hop Revolution 88

Embracing Risk Mindset

Episode Highlights

Challenges and Risks

Innovative Immune Mapping

Biotech Revolution

Related Episodes

HIBT Lab! Gro Intelligence: Sara Menker

HIBT Lab! Nas Company: Nuseir Yassin

HIBT Lab! Tomorrow.io: Shimon Elkabetz

HIBT Lab! Goodr: Jasmine Crowe-Houston

HIBT Lab! SOURCE Global: Cody Friesen

HIBT Lab! Wonder: Marc Lore

HIBT Lab! Colin and Samir: Colin Rosenblum and Samir Chaudry

ICYMI... HIBT Lab! Colin and Samir: Colin Rosenblum and Samir Chaudry

HIBT Lab! OpenAI: Sam Altman

HIBT Lab! Wildtype: Aryé Elfenbein and Justin Kolbeck

HIBT Lab! Armbrust American: Lloyd Armbrust

HIBT Lab! Biobot Analytics: Mariana Matus and Newsha Ghaeli

HIBT Lab! New Culture: Matt Gibson and Inja Radman

HIBT Lab! Universal Hydrogen: Paul Eremenko

HIBT Lab! Boom Supersonic: Blake Scholl

HIBT Lab! Immunai: Noam Solomon

Topics covered

Popular Clips

Episode Highlights

Challenges and RisksNoam Solomon, CEO of Immunai, discusses the company's innovative approach to drug development through risk-taking and collaboration. By mapping the human immune system, Immunai aims to revolutionize personalized medicine and improve clinical trial outcomes.

Challenges and Risks

Innovative Immune MappingNoam Solomon, CEO of Immunai, is transforming medicine by using AI to map the human immune system, aiming to accelerate the development of personalized drug therapies. His innovative approach promises to revolutionize how we understand and treat diseases like cancer.

Innovative Immune Mapping

Biotech RevolutionNoam Solomon discusses the challenges of developing immunotherapies and the transformative role of AI in biotech. He shares how Immunai's innovative approach aims to revolutionize drug development and personalize treatments.

Biotech Revolution

Related Episodes